Skip to main content
TipRanks
Go Ultimate75% OFF

CapForce (CFOR) AI Stock Analysis

598 Followers
CFOR

CapForce

(Other OTC:CFOR)

Select Model
Rating:40Underperform
Action:N/A
Date:01/17/25

OpGen's overall stock score is low due to significant financial challenges, including declining revenues, negative profitability, and reliance on external financing. Technical indicators suggest a bearish trend with potential overbought conditions, and valuation metrics highlight unprofitability. These factors collectively indicate substantial risk and uncertainty in the company's near-term performance.

Positive Factors
Revenue GrowthA 52% revenue growth rate indicates strong demand for OpGen's diagnostic products, suggesting robust market positioning and potential for sustained growth.
Negative Factors
Financial SustainabilityReliance on external funding and high leverage can threaten financial stability, limiting the company's ability to invest in growth and innovation.

CapForce (CFOR) vs. SPDR S&P 500 ETF (SPY)

-100%0%100%200%300%400%500%600%CFOR+12.10%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$63.14M
Dividend Yield
―
Average Volume (3M)
1,440
Price to Earnings (P/E)
1.1
Beta (1Y)
-10105.08
Revenue Growth
746.67%
EPS Growth
148.58%
Country
US
Employees
3
Sector
Financial
Sector Strength
68
Industry
Financial - Capital Markets

CapForce Business Overview & Revenue Model

Company Description

CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across inte...

How the Company Makes Money

OpGen generates revenue primarily through the sale of its diagnostic products and services. The company's revenue model is based on selling its molecular diagnostic tests, such as the Acuitas AMR Gene Panel and the Unyvero platform, to hospitals, lab...

CapForce Technical Analysis

Technical Analysis SentimentNegative
Last Price5.65

Price Trends

50DMA5.11Positive
100DMA7.58Negative
200DMA12.28Negative

Market Momentum

MACD0.61Positive
RSI46.01Neutral
STOCH26.37Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CFOR, the sentiment is Negative. The current price of 5.65 is below the 20-day moving average (MA) of 6.84, above the 50-day MA of 5.11, and below the 200-day MA of 12.28, indicating a neutral trend. The MACD of 0.61 indicates Positive momentum. The RSI at 46.01 is Neutral, neither overbought nor oversold. The STOCH value of 26.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CFOR.

CapForce Risk Analysis

CapForce disclosed 26 risk factors in its most recent earnings report. CapForce reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.We may not realize the anticipated benefits of our acquisition of iCapX, and integration and development of the platform may present challenges.Q4, 2025
2.We may pursue joint ventures or strategic partnerships in the future, which could involve risks that adversely affect our business.Q4, 2025
3.Our reliance on data and advanced computational model-enabled analytics presents risks related to data quality, regulatory oversight, and performance.Q4, 2025

CapForce Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

CFOR against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
ABTCABTC47Neutral$369.21M-4.28-10.23%―281.42%88.95%
CIFRCIFR46Neutral$3.13B-2.46-161.74%―-29.24%-1320.03%
HUTHUT46Neutral$6.91B-12.23-35.59%―71.33%-333.29%
BTBTBTBT42Neutral$239.00M-0.53-77.81%―11.28%-421.89%
MARAMARA41Neutral$2.71B-0.86-121.19%―-22.10%-420.07%
CFORCFOR40Underperform$70.41M1.12168.84%―746.67%148.58%

* Financial Sector Average

Performance Comparison

0%250%500%750%1000%CFORMARAABTCBTBTHUTCIFRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CFOR and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CFORCapforce Inc.5.652.85101.79%
MARAMARA Holdings, Inc6.99-4.52-39.27%
ABTCAmerican Bitcoin Corp.5.07-70.68-93.31%
BTBTBit Digital, Inc.0.66-1.64-71.26%
HUTHut 8 Corp.57.5719.8752.71%
CIFRCipher Digital Inc.6.86-7.49-52.20%

CapForce Corporate Events

Executive/Board ChangesPrivate Placements and Financing

OpGen amends financing deal and announces president’s resignation

Neutral
Dec 23, 2025

On December 17, 2025, OpGen, Inc. further amended its existing financing arrangement with AEI Capital Ltd. by signing a Supplemental Letter that extends the company’s ability to sell up to $9.0 million of its common stock to the investor under a prev...

Executive/Board Changes

OpGen Appoints New CEO Christian-Laurent Bonte

Neutral
Dec 5, 2025

On December 1, 2025, OpGen announced the resignation of John Tan Honjian from his role as Chief Executive Officer, although he will remain as Chairman of the Board. Christian-Laurent Bonte was appointed as the new CEO, bringing extensive investment b...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jan 17, 2025